- Home
- OABI vs AFRI Comparison
OABI vs AFRI Comparison
Compare OABI & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- AFRI
- Stock Information
- Founded
- OABI 2012
- AFRI 1943
- Country
- OABI United States
- AFRI Gibraltar
- Employees
- OABI N/A
- AFRI N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- AFRI Packaged Foods
- Sector
- OABI Health Care
- AFRI Consumer Staples
- Exchange
- OABI Nasdaq
- AFRI Nasdaq
- Market Cap
- OABI 227.4M
- AFRI 207.7M
- IPO Year
- OABI N/A
- AFRI N/A
- Fundamental
- Price
- OABI $1.66
- AFRI $8.55
- Analyst Decision
- OABI Strong Buy
- AFRI
- Analyst Count
- OABI 3
- AFRI 0
- Target Price
- OABI $6.67
- AFRI N/A
- AVG Volume (30 Days)
- OABI 595.9K
- AFRI 12.7K
- Earning Date
- OABI 11-11-2025
- AFRI 04-30-2025
- Dividend Yield
- OABI N/A
- AFRI N/A
- EPS Growth
- OABI N/A
- AFRI N/A
- EPS
- OABI N/A
- AFRI N/A
- Revenue
- OABI $23,027,000.00
- AFRI $274,223,000.00
- Revenue This Year
- OABI N/A
- AFRI N/A
- Revenue Next Year
- OABI $48.74
- AFRI N/A
- P/E Ratio
- OABI N/A
- AFRI N/A
- Revenue Growth
- OABI 6.05
- AFRI N/A
- 52 Week Low
- OABI $1.22
- AFRI $7.47
- 52 Week High
- OABI $4.87
- AFRI $11.20
- Technical
- Relative Strength Index (RSI)
- OABI 49.38
- AFRI 48.68
- Support Level
- OABI $1.58
- AFRI $8.45
- Resistance Level
- OABI $1.72
- AFRI $8.95
- Average True Range (ATR)
- OABI 0.08
- AFRI 0.31
- MACD
- OABI 0.02
- AFRI -0.04
- Stochastic Oscillator
- OABI 65.15
- AFRI 16.19
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.